CIR Review Summary May 6, 2026 3 min read

Alkyl PEG Ethers: CIR Safety Assessment Summary

CIR safety assessment summary for Alkyl PEG Ethers: ingredients reviewed, panel verdict, use concentration context, conditions, and source citation.

Alkyl PEG Ethers appears in a CIR safety assessment covering Alkyl PEG Ethers. The panel verdict for the report is safe with restrictions. Reference Previously Reviewed Ceteareth-2, -3, -4, -5, -6, -7, -8, -9, -10, -11, -12, -13, -14, -15, -16, -17, -18, -20, -22, -23, -24, -25, -27, -28, -29, -30, -33, -34, -40, -50, -55, -60, -80, -100 Safe as used 2 (continued) 172S International Journal of Toxicology 31(Supplement 2) Table 2A.

FieldCIR value
Primary ingredientAlkyl PEG Ethers
CIR verdictsafe with restrictions
Report typeSafety Assessment
DateIn 1983
CAS numbers9002-92-0, 68439-50-9, 5274-68-0, 9004-95-9, 9005-00-9, 4536-30-5, 3055-93-4, 3055-94-5, 3055-95-6, 3055-96-7, 3055-97-8, 3055-98-8, 3055-99-0, 24938-91-8, 68002-97-1, 6540-99-4, 4403-12-7, 26138-52-8, 26183-52-8, 5703-94-6, 69011-36-5, 78330-21-9, 27306-79-2, 26826-30-2, 39034-24-7, 34398-01-1, 16057-43-5, 4439-32-1, 59970-10-4, 127036-24-2
Use concentration context10%; 1.35%; 15%; 1.25%
Conditions or carve-outs

Ingredients Reviewed

The review scope matters because CIR conclusions often apply to an ingredient family rather than a single INCI name. In this report, the ingredient list includes Alkyl PEG Ethers.

Safety Conclusion

The conclusion for Alkyl PEG Ethers should be read as a CIR panel conclusion, not a regulatory limit. CIR assessments summarize expert-panel safety determinations for cosmetic use, while legal status still depends on the jurisdiction and product category.

For use levels, the report gives this concentration context: 10%; 1.35%; 15%; 1.25%. That language is the safe-use context shown for this page.

Conditions

Reference Previously Reviewed Ceteareth-2, -3, -4, -5, -6, -7, -8, -9, -10, -11, -12, -13, -14, -15, -16, -17, -18, -20, -22, -23, -24, -25, -27, -28, -29, -30, -33, -34, -40, -50, -55, -60, -80, -100 Safe as used 2 (continued) 172S International Journal of Toxicology 31(Supplement 2) Table 2A.

Formulation Reading

For formula review, begin with the exact INCI identity and the ingredient group covered by the CIR assessment. If the material is Alkyl PEG Ethers, the relevant comparison is whether the intended use aligns with the practices, concentration ranges, and conditions described in the CIR source.

The ingredient hub at Alkyl PEG Ethers should carry the substance-level profile. This page is the report-level summary, keeping the conclusion, ingredient scope, and use-context language attached to the CIR source rather than treating the conclusion as a universal permission.

Why This Page Exists

CIR reviews are long documents, and the practical answer is usually buried in the conclusion and the table of current practices. This summary keeps those CIR facts in one indexable page for Alkyl PEG Ethers, with source details retained at the bottom for audit.


Source

  • CIR report: Safety Assessment of Alkyl PEG Ethers as Used in Cosmetics Monice M. Fiume1, Bart Heldreth2, Wilma F. Bergfeld3, Donald V. Belsito3, Ronald A. Hill3, Curtis D. Klaassen3, Daniel Liebler3, James G. Marks, Jr3, Ronald C. Shank3, Thomas J. Sla
  • CIR source file: PRS581.pdf
  • Extraction JSON: CIR Safety Assessment Database
  • Conclusion page in CIR extraction: 4